TRAJ : Transition in Rheumatology, From Adolescence to Adulthood
ConditionTransitional Care
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux
About this trial
This study evaluates the impact of the CAPAdJA transition support program on care continuity for young patients with chronic rheumatic diseases at Bordeaux University Hospital. The primary objective is to compare the proportion of patients lost to follow-up six months after the transition consultation between those who benefited from CAPAdJA and those who did not.
Eligibility criteria
Qualifiers
Patients who benefited from a pediatric-to-adult rheumatology transition consultation at Bordeaux University Hospital between 2017 and 2024
Patients over 18 years old at the time of completing the self-administered questionnaire.
Disqualifiers
Patients who do not speak French
Patients who have refused to participating
Trial design
Treatments tested in this trial
- Self-questionnaire : satisfaction and quality of life
- Self-reported questionnaire : educational or professional
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov